Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Sep 26, 2013 brown michael s Director Automatic Sell 5,000 309.00
Jul 10, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 175,000 306.77 - 314.58
Sep 18, 2013 schleifer leonard s Officer Automatic Sell 115,440 304.38
Sep 18, 2013 vagelos p roy Officer Automatic Sell 167,144 304.38
Mar 7, 2014 sanofi Beneficial Owner (10% or more) Buy 69,873 304.21 - 325.82
Jul 9, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 195,000 304.19 - 311.91
Sep 18, 2013 roberts william Officer Automatic Sell 15,000 304.00
Mar 27, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 302.96 - 316.49
Sep 30, 2013 baker charles a Director Automatic Sell 15,000 302.46 - 319.13
Nov 6, 2013 goldstein joseph l Director Sell 1,000 300.74
Sep 19, 2013 vagelos p roy Officer Automatic Sell 145,356 300.34 - 310.18
Sep 19, 2013 schleifer leonard s Officer Automatic Sell 102,949 300.33 - 310.14
Mar 28, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 300.28 - 315.33
Mar 24, 2014 baker charles a Director Automatic Sell 15,000 300.09 - 313.40
Jan 14, 2014 gilman alfred g Director Automatic Sell 5,000 300.00
Mar 24, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 299.01 - 314.22
Jul 2, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 212,400 298.91 - 311.92
Sep 18, 2013 van plew daniel p Officer Automatic Sell 23,977 298.28 - 308.26
May 22, 2014 van plew daniel p Officer Disposition (Non Open Market) 5,831 296.19
Dec 2, 2013 vagelos p roy Officer Sell 95 296.11
Showing 121-140 of 935 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)